129 results for «100»
129 results
EuroPCR 2024 delivered an eye-opening focus on imaging guidance
24 May 2024
A record 12,100 participants from 130 countries have just taken part in the highly educational WorldLeading Course in interventional cardiovascular medicine. They enjoyed a unique opportunity to exchange their knowledge, skills and experience on a global scale.
Paris – France, 17 May 2024. As always, the thought-provoking...
GulfPCR-GIM 2024 Opening Ceremony
18 Dec 2024 – From GulfPCR-GIM 2024
The GulfPCR-GIM 2024 opening ceremony, live from Dubai, marks the start of this year’s premier interventional course in the Middle East. Building on the success of last year, which gathered over 1,100 participants and featured 50+ sessions, the 2024 edition promises an even richer program. Highlights...
The right therapy for right heart failure and tricuspid regurgitation: fixing my patient congestion, not just a valve
21 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session shifts the focus in tricuspid regurgitation from anatomy alone to the broader context of right heart failure and systemic congestion. It highlights the limitations of purely leaflet-based strategies, particularly in advanced disease and in the presence of severe right ventricular dysfunction.
The discussion...
Dangers of dissection: the role of ICI
20 May 2026 – From EuroPCR 2026
This session explores the critical role of intracoronary imaging (ICI) in diagnosing and managing coronary artery dissections. Cases include fenestration techniques, stent migration challenges, polytrauma patient management, route selection dilemmas, and intricate procedural navigation to achieve successful outcomes.
Iatrogenic causes for shock treated with LV support
21 May 2025 – From EuroPCR 2025
Explore the management of iatrogenic causes of cardiogenic shock requiring left ventricular support. This session presents complex cases including shock following Bentall procedures, complications during anesthesia induction in bypass surgery, and strategic approaches to prevent and manage these critical scenarios using LV support devices.
Large thrombus burden: contemporary solutions
21 May 2025 – From EuroPCR 2025
This session presents contemporary strategies for managing large thrombus burden in STEMI patients. Learn from expert cases demonstrating multiple effective approaches including modified manual thrombus aspiration guided by intravascular ultrasound (IVUS) and streamlined primary PCI techniques, essential for optimizing outcomes in complex thrombotic scenarios.
EuroPCR 2025: Elevate Your Skills at the Training Village
Increasing efficiency in CTO PCI
21 May 2026 – From EuroPCR 2026
Focused on increasing efficiency in CTO PCI, this session covers diverse technical approaches including overcoming unexpected anatomical barriers, multiple wiring techniques, microchannel selection in bifurcation lesions, managing tortuous right coronary artery CTOs, unconventional strategies for uncrossable CTOs, and adapting perspectives in patients with previous CABG.
Facing challenging CTO scenarios
17 May 2023 – From EuroPCR 2023
If you're looking for training in the treatment of chronic total occlusion, explore these diverse cases involving patients of different ages and with a variety of pathologies. Observe the strategies employed in each complex case to gain valuable knowledge and improve your skills in managing these...
The uncrossable lesion
16 May 2024 – From EuroPCR 2024
This session delves into the challenges of dealing with uncrossable and heavily calcified coronary lesions. It features a variety of cases showcasing the use of specialized techniques and tools, such as the excimer laser, to overcome these obstacles. The session emphasizes the importance of troubleshooting, utilizing...
Innovation in transcatheter mitral valve interventions
21 May 2026 – From EuroPCR 2026
This comprehensive session presents the latest innovations in transcatheter mitral valve interventions, highlighting cutting-edge devices and clinical experiences. Topics include early feasibility studies of novel hemivalve systems, first-in-human experiences with new mitral valve replacement technologies, advances in transcatheter edge-to-edge repair (TEER) with one-year outcome data, and...
Innovations in transcatheter aortic valve devices and techniques
22 May 2025 – From EuroPCR 2025
Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...
TAVI Essentials: From patient selection to procedural success
20 Mar 2026
Led by Ole De Backer, Christian Frerker and Alper Öner: a comprehensive expert-driven report covering the state of the art in aortic stenosis treatment.
The best of PCR Tokyo Valves 2026
Balloon pre-dilatation
04 Nov 2017
Learn more about balloon-expandable transcatheter aortic valve implantation with pre-dilatation of the aortic valve. Balloon aortic valvuloplasty is recommended prior to valve implantation but may contribute to procedural risk.
PCR Tokyo Valves 2026: Your travel guide featuring upcoming exclusive booking services and special deals.
PCR's Got Talent - Round 1 - Session 1
14 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, showcases a variety of research topics in the field of interventional cardiology. It includes presentations and discussions on sex differences in outcomes of percutaneous thrombectomy for pulmonary embolism, the validation of the MIRACLE2 score in OHCA patients, the...
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
31 Aug 2021
Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.
Author
Become a PCR Companion for free!
11 Apr 2019
Join the heart of the PCR Community, access exclusive advantages, and earn recognition for your contributions.
MagicTouch SCB receives IDE approval for In-Stent Restenosis indication.
17 Sep 2022